FILE PHOTO: Vials with a sticker reading "COVID-19/Coronavirus vaccine/Injection only" and a syringe are seen in front of a displayed Moderna logo in this illustration taken October 31, 2020. REUTERS/Dado Ruvic/Illustration/File Photo
ZURICH (Reuters) - Switzerland has begun a rolling review of Moderna's, COVID-19 vaccine candidate so it can give it a speedy approval should it pass muster in clinical trials, the country's drug regulator said on Friday.
Regulator Swissmedic is already scrutinizing the progress of experimental vaccines being developed by AstraZeneca as well as Pfizer and BioNTech SE in similar rolling reviews.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
